NCT07105137

Brief Summary

This cluster-randomized controlled trial aims to evaluate the efficacy of an AI-assisted Guided Narrative Writing (AI-GNW) in alleviating emotional distress among adolescents. Classes will be randomized in a 1:1:1 ratio to one of three arms-AI-GNW, a no-feedback GNW (NF-GNW), or a Neutral Writing Group (NWG)-and will complete a three-day writing intervention. On the first day, participants in both GNW conditions will recount a negative experience and reflect on their thoughts and feelings; on the second day, they will focus exclusively on the negative aspects of that experience; and on the third day, they will explore its positive dimensions. In contrast, NWG participants will objectively document their previous day's daily routine. After each session, those in the AI-GNW arm will receive individualized, AI-generated feedback, whereas NF-GNW participants will proceed without feedback.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
900

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started May 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 16, 2025

Completed
3 days until next milestone

Study Start

First participant enrolled

May 19, 2025

Completed
3 months until next milestone

First Posted

Study publicly available on registry

August 5, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2025

Completed
Last Updated

August 5, 2025

Status Verified

July 1, 2025

Enrollment Period

6 months

First QC Date

May 16, 2025

Last Update Submit

July 29, 2025

Conditions

Keywords

AI-assistedExpressive writingAdolesentsEmotional distressInsomnia

Outcome Measures

Primary Outcomes (2)

  • Revised Child Anxiety and Depression Scale (RCADS)

    RCADS is a 25-item scale that includes 15 items for general anxiety and 10 for depression, rated on a 4-point Likert scale (0 = never, 3 = always). Higher scores mean more severe emotional distress

    Baseline (day 0), post-intervention (day 4), and follow-ups at 1 (day 34),3 (day 64), and 6 (day 94) months after the intervention.

  • Insomnia Severity Index (ISI)

    ISI is a 7-item, 5-point (0-4) Likert scale. Higher scores mean higher insomnia severity.

    Baseline (day 0), post-intervention (day 4), and follow-ups at 1 (day 34),3 (day 64), and 6 (day 94) months after the intervention.

Secondary Outcomes (3)

  • Non-Suicidal Self-Injury Assessment Tool (NSSI-AT)

    Baseline (day 0), post-intervention (day 4), and follow-ups at 1 (day 34),3 (day 64), and 6 (day 94) months after the intervention.

  • Suicidal Behaviors Questionnaire-Revised (SBQ-R)

    Baseline (day 0), post-intervention (day 4), and follow-ups at 1 (day 34),3 (day 64), and 6 (day 94) months after the intervention.

  • Chinese PTSD Symptom Scale (CPSS)

    Baseline (day 0), post-intervention (day 4), and follow-ups at 1 (day 34),3 (day 64), and 6 (day 94) months after the intervention.

Other Outcomes (6)

  • Adverse Childhood Experience Questionnaire (ACE)

    Baseline (day 0)

  • Beijing Irritability Scale (BIS)

    Baseline (day 0), post-intervention (day 4), and follow-ups at 1 (day 34),3 (day 64), and 6 (day 94) months after the intervention.

  • Positive Childhood Experience Questionnaire (PCE)

    Baseline (day 0)

  • +3 more other outcomes

Study Arms (3)

AI-GNW

EXPERIMENTAL
Behavioral: AI-GNW

NF-GNW

ACTIVE COMPARATOR
Behavioral: NF-GNW

NWG

SHAM COMPARATOR
Behavioral: NWG

Interventions

AI-GNWBEHAVIORAL

This is a three-day writing intervention. Each session lasts 20 minutes. On the first day, participants in both GNW conditions will recount a negative experience and reflect on their thoughts and feelings; on the second day, they will focus exclusively on the negative aspects of that experience; and on the third day, they will explore its positive dimensions. AI-GNW participants would receive AI-generated feedback.

AI-GNW
NF-GNWBEHAVIORAL

guided narrative writing without feedbacks

NF-GNW
NWGBEHAVIORAL

In contrast, NWG participants will objectively document their previous day's daily routine.

NWG

Eligibility Criteria

Age10 Years - 19 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Native speakers of Chinese who are proficient in reading and writing Chinese.
  • Signed a informed consent form and voluntarily agreed to participate.
  • Owns a smartphone, tablet, or similar electronic device and is able to complete the required questionnaires and writing tasks.

You may not qualify if:

  • Prior clinical diagnosis of schizophrenia or any other major psychiatric disorder.
  • Presence of severe cognitive impairment, language-expression difficulties, or any other condition that would impede writing ability.
  • Participation in another similar psychological intervention or psychotherapy within the past three months.
  • Inability to tolerate a group-based intervention setting due to personal health conditions (e.g., serious illness).
  • Unwillingness or inability to provide necessary cooperation or to sign the informed consent form.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Peking University

Haidian, Beijing Municipality, 100871, China

Location

MeSH Terms

Conditions

Affective SymptomsEmotional RegulationSleep Initiation and Maintenance Disorders

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehaviorSelf-ControlSocial BehaviorSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesMental Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
To maintain rigorous protection against bias, allocation to the AI-GNW, NF-GNW, or NWG arms was concealed from participants, interventionists, and those responsible for outcome evaluation. Participants were informed only that they would engage in a writing exercise and were unaware of the nature or content of the feedback provided in the AI-GNW arm. Investigators who facilitated the sessions did not have access to the randomization schedule or to any identifying information about group assignment. Outcomes assessors remained blind to each participant's study arm. This triple-masking procedure ensured that neither expectations nor assessment procedures could differentially influence intervention delivery or measurement of study endpoints.
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 16, 2025

First Posted

August 5, 2025

Study Start

May 19, 2025

Primary Completion

November 1, 2025

Study Completion

November 1, 2025

Last Updated

August 5, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

To protect participants' privacy, authors wishing to access the data should contact the corresponding author and provide a statistical analysis plan addressing a new research question. The study trial management group will discuss all requests.

Locations